Skip to main content
Top
Published in: Indian Journal of Pediatrics 2/2016

01-02-2016 | Original Article

Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia

Authors: Ramaswamy Ganesh, Natarajan Suresh, Lalitha Janakiraman, Karnam Ravikumar

Published in: Indian Journal of Pediatrics | Issue 2/2016

Login to get access

Abstract

Objective

To correlate the bone mineral parameters [bone mineral content (BMC) and bone mineral density (BMD)] using Dual energy X ray Absorptiometry (DXA) scan with anthropometric measurements and to study the effect of glucocorticoid therapy on BMC/BMD in children with Congenital adrenal hyperplasia (CAH).

Methods

A cross-sectional study was carried out in the Pediatric Endocrinology unit from January 2012 through March 2013 at Kanchi Kamakoti CHILDS Trust hospital, Chennai. Thirteen CAH children aged 0–132 mo with classic salt wasting due to 21 hydroxylase deficiency were included in the study. All children were treated with T.hydrocortisone @10–15 mg/m2/d twice daily and T. fludrocortisone 50 μg once daily orally at the time of enrollment into the study. The duration of glucocorticoid (hydrocortisone) treatment from the date of diagnosis till the time of enrollment into the study was noted and categorized as children receiving <5 and >5 y of glucocorticoid therapy. None received Vitamin D/calcium supplementation at the time of enrollment. BMC and areal BMD for the lumbar spine and total body less head (TBLH) were measured with Lunar DXA machine.

Results

The mean height, weight and BMI of children were 87.3 ± 33 cm, 13.49 ± 11.2 kg and 14 ± 4.07 kg/m2 respectively. TBLH BMC was 369.14 ± 312.18 g and TBLH BMD was 0.63 ± 0.11 g/cm2. There was a significant correlation between height and total body less head BMC/BMD in the index series [P < 0.05, significant]. The TBLH and spine BMD were also assessed with regards to the duration of glucocorticoid therapy and it has been observed that TBLH and spine BMD decreased with increased duration of steroid therapy (p < 0.05, significant).

Conclusions

In the absence of normative data or z scores, BMC/BMD correlates well with height for age. Children who received more than 5 y of glucocorticoid treatment had lower TBLH and spine BMD scores and hence, calcium and Vitamin D supplementation should be considered.
Literature
1.
go back to reference Nimkarn S, Lin-Su K, New MI. Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia. Endocrinol Metab Clin N Am. 2009;38:699–718.CrossRef Nimkarn S, Lin-Su K, New MI. Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia. Endocrinol Metab Clin N Am. 2009;38:699–718.CrossRef
2.
go back to reference Gussinyé M, Carrascosa A, Potau N, et al. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. Pediatrics. 1997;100:671–4.CrossRefPubMed Gussinyé M, Carrascosa A, Potau N, et al. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. Pediatrics. 1997;100:671–4.CrossRefPubMed
3.
go back to reference Paganini C, Radetti G, Livieri C, Braga V, Migliavacca D, Adami S. Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Horm Res. 2000;54:164–8.CrossRefPubMed Paganini C, Radetti G, Livieri C, Braga V, Migliavacca D, Adami S. Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Horm Res. 2000;54:164–8.CrossRefPubMed
4.
go back to reference Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18:1319–28.CrossRefPubMed Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18:1319–28.CrossRefPubMed
5.
go back to reference Chakhtoura Z, Bachelot A, Samara-Boustani D, et al. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency. Eur J Endocrinol. 2008;158:879–87.CrossRefPubMed Chakhtoura Z, Bachelot A, Samara-Boustani D, et al. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency. Eur J Endocrinol. 2008;158:879–87.CrossRefPubMed
6.
go back to reference Baxter JD. Advances in glucocorticoid therapy. Adv Intern Med. 2000;45:317–49.PubMed Baxter JD. Advances in glucocorticoid therapy. Adv Intern Med. 2000;45:317–49.PubMed
7.
go back to reference Petak S, Barbu CG, Yu EW, et al. The official positions of the international society for clinical densitometry: body composition analysis reporting. J Clin Densitom. 2013;16:508–19. Petak S, Barbu CG, Yu EW, et al. The official positions of the international society for clinical densitometry: body composition analysis reporting. J Clin Densitom. 2013;16:508–19.
8.
go back to reference Khadilkar AV, Sanwalka NJ, Chiplonkar SA, Khadilkar VV, Mughal MZ. Normative data and percentile curves for dual energy X-ray absorptiometry in healthy Indian girls and boys aged 5–17 y. Bone. 2011;48:810–9.CrossRefPubMed Khadilkar AV, Sanwalka NJ, Chiplonkar SA, Khadilkar VV, Mughal MZ. Normative data and percentile curves for dual energy X-ray absorptiometry in healthy Indian girls and boys aged 5–17 y. Bone. 2011;48:810–9.CrossRefPubMed
9.
go back to reference Elnecave RH, Kopacek C, Rigatto M, Keller Brenner J, de Castro JAS. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency. J Pediatr Endocrinol Metab. 2008;21:1155–62.PubMed Elnecave RH, Kopacek C, Rigatto M, Keller Brenner J, de Castro JAS. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency. J Pediatr Endocrinol Metab. 2008;21:1155–62.PubMed
10.
go back to reference Ekbote VH, Khadilkar AV, Chiplonkar SA, Khadilkar VV. Determinants of bone mineral content and bone area in Indian preschool children. J Bone Miner Metab. 2011;29:334–41.CrossRefPubMed Ekbote VH, Khadilkar AV, Chiplonkar SA, Khadilkar VV. Determinants of bone mineral content and bone area in Indian preschool children. J Bone Miner Metab. 2011;29:334–41.CrossRefPubMed
11.
go back to reference Hagenfeldt K, Martin Ritzén E, Ringertz H, Helleday J, Carlström K. Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. Eur J Endocrinol. 2000;143:667–71.CrossRefPubMed Hagenfeldt K, Martin Ritzén E, Ringertz H, Helleday J, Carlström K. Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. Eur J Endocrinol. 2000;143:667–71.CrossRefPubMed
12.
go back to reference Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006;91:4453–8.CrossRefPubMed Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006;91:4453–8.CrossRefPubMed
13.
go back to reference Girgis R, Winter JS. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1997;82:3926–9.CrossRefPubMed Girgis R, Winter JS. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1997;82:3926–9.CrossRefPubMed
14.
go back to reference Cetinkaya S, Kara C. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2011;24:265–9.PubMed Cetinkaya S, Kara C. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2011;24:265–9.PubMed
15.
go back to reference Reid IR, Evans MC, Wattie DJ, Ames R, Cundy TF. Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients. Osteoporos Int. 1992;2:103–5.CrossRefPubMed Reid IR, Evans MC, Wattie DJ, Ames R, Cundy TF. Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients. Osteoporos Int. 1992;2:103–5.CrossRefPubMed
16.
go back to reference Bachelot A, Chakhtoura Z, Samara-Boustani D, Dulon J, Touraine P, Polak M. Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency. Int J Pediatr Endocrinol. 2010. doi:10.1155/2010/326275.PubMedCentralPubMed Bachelot A, Chakhtoura Z, Samara-Boustani D, Dulon J, Touraine P, Polak M. Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency. Int J Pediatr Endocrinol. 2010. doi:10.​1155/​2010/​326275.PubMedCentralPubMed
Metadata
Title
Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia
Authors
Ramaswamy Ganesh
Natarajan Suresh
Lalitha Janakiraman
Karnam Ravikumar
Publication date
01-02-2016
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 2/2016
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-015-1835-y

Other articles of this Issue 2/2016

Indian Journal of Pediatrics 2/2016 Go to the issue